| Prev Close: | 101.50 |
|---|---|
| Open: | 101.69 |
| Bid: | 91.00 x 100 |
| Ask: | 101.00 x 100 |
| 1y Target Est: | 113.41 |
| Beta: | 0.43 |
| Next Earnings Date: | 22-Jul-13 |
| Day's Range: | 99.15 - 102.00 |
|---|---|
| 52wk Range: | 70.88 - 114.95 |
| Volume: | 3,825,420 |
| Avg Vol (3m): | 3,862,050 |
| Market Cap: | 74.38B |
| P/E (ttm): | 16.79 |
| EPS (ttm): | 5.91 |
| Div & Yield: | 1.88 (1.90%) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Final Glance: Biotechnology companiesAP(Wed 6:05PM EDT)
- [video] Five Candidates to Succeed Ben Bernanke at Fedat MarketWatch(Wed 5:25PM EDT)
- Amgen Award For Science Teaching Excellence Honors Outstanding TeachersPR Newswire(Wed 4:02PM EDT)
- Midday Glance: Biotechnology companiesAP(Wed 1:20PM EDT)
- This Blockbuster Biologic May Face a Steep Cliffat Motley Fool(Wed 10:46AM EDT)
- Early Glance: Biotechnology companiesAP(Wed 10:33AM EDT)
- Amgen In Focusat Seeking Alpha(Wed 9:13AM EDT)
- Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account ReconciliationsPR Newswire(Wed 9:02AM EDT)
- Three Attractive, Future Dividend Achieversat Motley Fool(Tue, Jun 18)
- Top Treatments for High Cholesterolat Motley Fool(Tue, Jun 18)
- InPlay: Amgen displays early relative strength but stalls shy of its June high and 50 ema at 101.25/101.31 -- session high 100.99Briefing.com(Tue, Jun 18)
- Amgen Xgeva Label ExpandedZacks(Mon, Jun 17)
- American Generics Can't Touch This $8 Billion Drug (Yet)at Motley Fool(Mon, Jun 17)
- 5 Stocks Raising The Drugs Industry Higherat TheStreet(Mon, Jun 17)
- Huge Upside on Pipeline Strengthat Motley Fool(Mon, Jun 17)
Press Releases
- Amgen Award For Science Teaching Excellence Honors Outstanding TeachersPR Newswire(Wed 4:02PM EDT)
- Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account ReconciliationsPR Newswire(Wed 9:02AM EDT)
- FDA Approves Amgen's XGEVA® (denosumab) For The Treatment Of Giant Cell Tumor Of BonePR Newswire(Thu, Jun 13)
Reports
- AMGN: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(Jun 19)
- ValuEngine Industry Report for Medical-biomed/geneticsValuEngine, Inc.(Jun 19)
- Trading Report for (AMGN). A detailed report, including free correlated market...Stock Traders Daily(Jun 19)